These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7966792)

  • 1. Transitional cell carcinoma: a common sense approach.
    Badalament RA
    J Urol; 1995 Jan; 153(1):61-2. PubMed ID: 7966792
    [No Abstract]   [Full Text] [Related]  

  • 2. The conundrum of prostatic urethral involvement.
    Ingimarsson JP; Seigne JD
    Urol Clin North Am; 2013 May; 40(2):249-59. PubMed ID: 23540782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra.
    Bretton PR; Herr HW; Whitmore WF; Badalament RA; Kimmel M; Provet J; Oettgen HF; Melamed MR; Fair WR
    J Urol; 1989 Apr; 141(4):853-6. PubMed ID: 2926879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 5. Bladder cancer.
    Soloway MS
    Urology; 1996 Oct; 48(4):631. PubMed ID: 8886073
    [No Abstract]   [Full Text] [Related]  

  • 6. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical bacillus Calmette-Guerin for the treatment of superficial transitional cell carcinoma of the prostatic urethra in association with carcinoma of the bladder.
    Schellhammer PF; Ladaga LE; Moriarty RP
    J Urol; 1995 Jan; 153(1):53-6. PubMed ID: 7966790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin.
    Hillyard RW; Ladaga L; Schellhammer PF
    J Urol; 1988 Feb; 139(2):290-3. PubMed ID: 3339727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Tumors of the urethra in men and women.
    Grabstald H
    Cancer; 1973 Nov; 32(5):1236-55. PubMed ID: 4757914
    [No Abstract]   [Full Text] [Related]  

  • 11. In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate.
    Palou J; Xavier B; Laguna P; Montlleó M; Vicente J
    Urology; 1996 Apr; 47(4):482-4. PubMed ID: 8638354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of heterotransplantation of transplantable human urogenital malignant neoplasms. Part VII. Combined chemo-radiation therapy of human urinary bladder cancer and human prostatic cancer transplantable to nude mice].
    Hasegawa J
    Nihon Hinyokika Gakkai Zasshi; 1985 Apr; 76(4):473-82. PubMed ID: 4032908
    [No Abstract]   [Full Text] [Related]  

  • 13. Intrascotal metastasis of bladder transitional cell carcinoma as initial presentation of the disease.
    Fragkoulis C; Papadopoulos G; Gkialas I; Ntoumas K
    J BUON; 2016; 21(6):1565-1566. PubMed ID: 28039727
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives on Geriatric Oncology Research presented at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium.
    Shen J; Prentice M; Pollock Y; Franca M; Kanesvaran R
    J Geriatr Oncol; 2019 Jul; 10(4):523-525. PubMed ID: 30982753
    [No Abstract]   [Full Text] [Related]  

  • 15. Bibliography. Current world literature. Genitourinary system.
    Curr Opin Oncol; 1999 May; 11(3):B116-30. PubMed ID: 10328603
    [No Abstract]   [Full Text] [Related]  

  • 16. [Urethral recurrence of invasive carcinoma following BCG treatment for bladder Ca in situ].
    Ruoppolo M; Gozo M; Milesi R; Spina R; Fragapane G
    Urologia; 2010; 77 Suppl 17():72-7. PubMed ID: 21308679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of urethral recurrence following radical cystectomy and ileal bladder substitution.
    Varol C; Thalmann GN; Burkhard FC; Studer UE
    J Urol; 2004 Sep; 172(3):937-42. PubMed ID: 15311003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new staging system for transitional cell carcinoma involvement of the prostate and reconfirmation studies of intravesical therapy for superficial bladder cancer.
    Hudson MR
    J Urol; 1996 Sep; 156(3):972-4. PubMed ID: 8709376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of lower urinary tract and pelvic malignancies by the transcatheter chemotherapy of the gluteus inferior artery and by embolization of the internal iliac artery].
    Xu ZZ; Su HQ; Chen DX
    Zhonghua Wai Ke Za Zhi; 1985 May; 23(5):284-5, 318. PubMed ID: 4017788
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful management of metastatic urethral cancer with organ preservation.
    Kent D; Gee JR; Amato RJ; Pisters LL
    J Urol; 2001 Dec; 166(6):2308. PubMed ID: 11696764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.